Washington University, est. 2013St. Louis, Missouri
← All teams
Cohort 13
ColoStim

Slow-transit constipation, a subtype of chronic constipation caused by colonic dysmotility, affects an estimated 2-4% of people worldwide (about 6.7-13.4 million in the US), and common treatments such as laxatives do not address the underlying dysmotility. Clinicians treating colonic dysmotility using dry needling electrical stimulation (DNES) need a method to standardize needle placement and objectively evaluate colonic muscle activity to improve treatment outcomes for individuals struggling with colonic dysmotility.

ColoStim
Led by Gabriela HakemanVisit ColoStim

The solution

ColoStim is a single portable device that guides needle placement, delivers stimulation, and measures muscle activity to track muscle rehabilitation, so clinicians can treat colonic dysmotility safely and with objective data to inform and optimize treatment delivery.

The team

Gabriela Hakeman
Team lead

Gabriela Hakeman

Heather Sutkus
Team member

Heather Sutkus

Claire Anderson
Team member

Claire Anderson